Affordable Medicines

Statement, May 2017

South Centre Statement to the 10th NAM Health Ministerial

Below is a statement made by the South Centre’s Deputy Executive Director Vicente Paolo B. Yu III during the meeting of the Ministers of health of the Non-Aligned Movement held in Geneva on 23 May 2017 in conjunction with the World Health Assembly.

(more…)

Research Paper 77, May 2017

Access to Hepatitis C Treatment: A Global Problem

“Viral hepatitis is an international public health challenge, comparable to other major communicable diseases, including HIV, tuberculosis and malaria. Despite the significant burden it places on communities across all global regions, hepatitis has been largely ignored as a health and development priority until recently”. – WHO, Global Health Sector strategy on viral Hepatitis 2016-2021: Towards ending viral hepatitis

(more…)

SC Side Event to WHA70, 24 May 2017

Title:              Impact of the recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines: Discussion in the context of the 2030 Agenda for Sustainable Development

Date:              Wednesday, 24 May 2017, 18:00-19:30

Venue:           Room 7, Palais des Nations, Geneva, Switzerland

Organizers:  The South Centre, Morocco, Bolivia, India, Uganda, Venezuela, UNSG HLP A2M, PPD

(more…)

SC Breakfast Dialogue on Access to Hepatitis C Treatments, 16 May 2017

Title:               Breakfast Dialogue on Access to Hepatitis C Treatments

                           with Former President of Colombia H.E. Mr. Ernesto Samper Pizano

Date:                16 May 2017, 9:00-11:00

Venue:            Intercontinental Hotel

Organizers:  The South Centre,  Permanent Mission of the Republic of Ecuador, Coalition PLUS, UNITAID

(more…)

Policy Brief 39, May 2017

Highlights of the WHO Executive Board: 140th Session

The World Health Assembly (WHA), the highest body of the World Health Organization, will be meeting from 22-31 May 2017.

Earlier in January, the Executive Board of the WHO met and discussed on various strategic issues that will be carried forward to the WHA.

In this light, the South Centre has prepared a timely summary report in the form of a policy brief of the discussions that took place at the EB, to assist delegates and other stakeholders in their preparation for the discussions in the WHA.

(more…)

Policy Brief 37, March 2017

The Need to Avoid “TRIPS-Plus” Patent Clauses in Trade Agreements

A recent article in a prestigious journal reminds us of how the intellectual property chapter of free trade agreements can prevent the sick from getting treatment.  This article also critiques the TPP clauses and warns that they should not be translated to national laws or copied into other FTAs being negotiated. 
(more…)

Analytical Note, March 2017

The TRIPS and WTO Negotiations: Stakes for Africa

This paper discusses the current negotiation issues in the context of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) and the position the African Group has taken in these negotiations. (more…)

Research Paper 74, February 2017

Mitigating the Regulatory Constraints Imposed by Intellectual Property Rules under Free Trade Agreements

IP provisions in FTAs may have implications on a wide range of public policy areas. A vast academic literature has addressed the “flexibilities” available under the TRIPS Agreement and the negative impact of FTAs in relation to access to medicines. (more…)

SC Side Event to the TRIPS Council, 1 March 2017

Title:             The United Nations Secretary-General’s High Level Panel on Access to Medicines: Opportunities to  Advance Health Technology Innovation and Access

Date:              1 March 2017, 13:00-15:00

Venue:           Room S1, WTO Building, Centre William Rappard, Rue de Lausanne 154, Geneva

Organizers:   Bangladesh, Brazil, India, South Africa, the Secretariat of the UN Secretary-General’s High Level Panel on Access to Medicines, the South Centre

(more…)

South Centre Conference, 13 February 2017

Title:              Briefing for Developing Countries on Global Trends and Linkages to Geneva Multilateral    

                         Processes

Date:              Monday, 13 February 2017, 9:30-13:00

Venue:           Room XXIV, Palais des Nations

Organizer:   The South Centre

(more…)

Press release, 3 February 2017

Growing Coalition to Intensify Efforts to Address Global Antimicrobial Resistance

The South Centre supports increased global and national level advocacy for policy change and action to prevent the post-antibiotic era from becoming a bleak reality. This effort is being strengthened with the recent addition of five leading environmental and public health organizations to the Antibiotic Resistance Coalition (ARC). The ARC is an independent coalition of members from six continents working in health, agriculture, consumer, and development sectors. (more…)

Statement, January 2017

South Centre Statement on the Amendment to the WTO TRIPS Agreement to Ease Access to Affordable Medicine

An amendment to the TRIPS Agreement that aims to facilitate the access to affordable medicines has entered into force upon approval by two thirds of the WTO members. The amendment reflects the recognition by WTO Members of the need for the continued enhancement of global intellectual property rules to allow Members to systematically take measures to protect public health.

(more…)


CHF 0.000 items